A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

被引：8

作者：

Patruno, Cataldo ^{[1
]}

Fabbrocini, Gabriella ^{[2
]}

Lauletta, Giuseppe ^{[2
]}

Boccaletti, Valeria ^{[3
]}

Colonna, Cristiana ^{[4
]}

Cavalli, Riccardo ^{[4
]}

Neri, Iria ^{[5
]}

Ortoncelli, Michela ^{[6
]}

Schena, Donatella ^{[7
]}

Stingeni, Luca ^{[8
]}

Hansel, Katharina ^{[8
]}

Piccolo, Vincenzo ^{[9
]}

Di Brizzi, Veronica ^{[9
]}

Potenza, Concetta ^{[10
]}

Tolino, Ersilia ^{[10
]}

Bianchi, Luca ^{[11
]}

Manti, Sara ^{[11
]}

De Pasquale, Rocco ^{[12
]}

Di Lernia, Vito ^{[13
]}

Caminiti, Lucia ^{[14
]}

Galli, Elena ^{[15
]}

Coppo, Paola ^{[16
]}

Chiricozzi, Andrea ^{[17
,18
]}

De Simone, Clara ^{[17
,18
]}

Guerriero, Cristina ^{[17
]}

Amoruso, Fabrizio Giuseppe ^{[19
]}

Provenzano, Eugenio ^{[19
]}

Leonardi, Salvatore ^{[20
]}

Licari, Amelia ^{[21
]}

Marseglia, Gian Luigi ^{[21
]}

Palermo, Antonino ^{[22
]}

Di Pillo, Sabrina ^{[23
]}

Russo, Daniele ^{[23
]}

Moschese, Viviana ^{[24
]}

Patella, Vincenzo ^{[25
]}

Peduto, Tiziana ^{[25
]}

Ferreli, Caterina ^{[26
]}

Zangari, Paola ^{[27
]}

Veronese, Federica ^{[28
]}

Berti, Samantha Federica ^{[29
]}

Gruber, Michaela ^{[30
]}

Pezzolo, Elena ^{[31
]}

Termine, Stefania ^{[32
]}

Satta, Rosanna ^{[33
]}

Dragoni, Federica ^{[34
]}

Esposito, Maria ^{[35
]}

Fargnoli, Maria Concetta ^{[35
]}

Chiodini, Paolo ^{[9
]}

Vallone, Ylenia ^{[2
]}

di Vico, Francesca ^{[2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy

[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[3] Univ Brescia, Dept Med, Sect Dermatol, Brescia, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Pediat Dermatol Unit, Milan, Italy

[5] Univ Bologna, Unit Dermatol, IRCCS AOU Policlin S Orsola, Bologna, Italy

[6] Univ Turin, Dept Med Sci, Div Dermatol, Turin, Italy

[7] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[8] Univ Perugia, Dept Med & Surg, Dermatol Sect, Perugia, Italy

[9] Univ Campania Luigi Vanvitelli, Dermatol Unit, Caserta, Italy

[10] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Dermatol Unit Daniele Innocenzi, Polo Pontino, Latina, Italy

[11] Univ Tor Vergata, Syst Med Dept, Dermatol Unit, Policlin Tor Vergata, Rome, Italy

[12] Osped San Marco, UO Dermatol, Catania, Italy

[13] Azienda USL IRCCS Reggio Emilia, Dermatol Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[14] Univ Messina, Policlin Hosp, Messina, Italy

[15] Osped San Pietro Fatebenefratelli, UOS Immuno Allergol Eta evolut, Rome, Italy

[16] Regina Margher Childrens Hosp Citta Salute & Sci T, Pediat Endocrinol Unit, Turin, Italy

[17] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, Rome, Italy

[18] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslazionale, Dermatol, Rome, Italy

[19] Azienda Osped Cosenza, Dermatol Unit, Cosenza, Italy

[20] Univ Catania, San Marco Hosp, Dept Clin & Expt Med, Pediat Resp Unit, Catania, Italy

[21] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Pediat, Pediat Clin, Pavia, Italy

[22] Garibaldi Hosp, Dept Pediat, Catania, Italy

[23] Univ G dAnnunzio, Dept Pediat, Pediat Allergy & Pulmonol Unit, Chieti, Italy

[24] Univ Roma Tor Vergata, Pediat Allergol & Immunol Unit, Policlin Tor Vergata, Rome, Italy

[25] Santa Maria Speranza Hosp, Dept Med, Div Allergy & Clin Immunol, Battipaglia, SA, Italy

[26] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy

[27] Bambino Gesu Pediat Hosp, Acad Dept Pediat DPUO, Res Unit Clin Immunol & Vaccinol, IRCCS, Rome, Italy

[28] AOU Maggiore Car Hosp, Dermatol Clin, Novara, Italy

[29] Univ Florence, Dept Surg & Translat Med, Dermatol Unit, Florence, Italy

[30] Cent Hosp Bolzano, Dept Pediat, Bolzano, Italy

[31] Osped San Bortolo, Dermatol Unit, Vicenza, Italy

[32] Santa Chiara Hosp, Div Dermatol, Trento, Italy

[33] Univ Sassari, Dipartimento Sci Med Chirurg & Sperimentali, Sassari, Italy

[34] UOC Dermatol Osped San Donato, Arezzo, Italy

[35] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2023年 / 34卷 / 01期

关键词：

Atopic dermatitis; children; dupilumab; real-world data;

D O I：

10.1080/09546634.2023.2246602

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Dupilumab has been shown to be a safe and effective drug for the treatment of atopic dermatitis (AD) in children from 6 months to 11 years in randomized clinical trials. Aim: The aim of this real-life study was to determine the effectiveness in disease control and safety of dupilumab at W52 in moderate-to-severe AD children aged 6-11 years. Methods: All data were collected from 36 Italian dermatological or paediatric referral centres. Dupilumab was administered at label dosage with an induction dose of 300 mg on day 1 (D1), followed by 300 mg on D15 and 300 mg every 4 weeks (Q4W). Treatment effect was determined as overall disease severity, using EASI, P-NRS, S-NRS and c-DLQI at baseline, W16, W24, and W52. Ninety-six AD children diagnosed with moderate-to-severe AD and treated with dupilumab were enrolled. Results: Ninety-one (94.8%) patients completed the 52-week treatment period and were included in the study. A significant improvement in EASI score, P-NRS, S-NRS and c-DLQI was observed from baseline to weeks 16, 24 and 52. Conclusions: Our real-life data seem to confirm dupilumab effectiveness and safety in paediatric patients. Moreover, our experience highlighted that patients achieving clinical improvement at W16 preserved this condition over time.

引用

页数：6

共 50 条

[1] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study
Gargiulo, L.
Ibba, L.
Piscazzi, F.
Alfano, A.
Ingurgio, R. Cascio
Valenti, M.
Costanzo, A.
Narcisi, A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : e152 - e154
[2] Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study
Vignoli, Carlo Alberto
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[3] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
Berna-Rico, Emilio
Fiz-Benito, Esther
Busto-Leis, Jose Manuel
Servera-Negre, Guillermo
de Lucas-Laguna, Raul
Feito-Rodriguez, Marta
DERMATOLOGY, 2024, 240 (02) : 337 - 342
[4] A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis
Stingeni, Luca
Bianchi, Leonardo
Antonelli, Elettra
Caroppo, Elena Sofia
Ferrucci, Silvia Mariel
Gurioli, Carlotta
Ortoncelli, Michela
Fabbrocini, Gabriella
Nettis, Eustachio
Schena, Donatella
Napolitano, Maddalena
Gola, Massimo
Bonzano, Laura
Rossi, MariaTeresa
Belloni Fortina, Anna
Balato, Anna
Peris, Ketty
Foti, Caterina
Guarneri, Fabrizio
Romanelli, Marco
Patruno, Cataldo
Savoia, Paola
Esposito, Maria
Russo, Filomena
Errichetti, Enzo
Bianchelli, Tommaso
Bianchi, Luca
Pellacani, Giovanni
Feliciani, Claudio
Offidani, Annamaria
Corazza, Monica
Micali, Giuseppe
Milanesi, Nicola
Malara, Giovanna
Chiricozzi, Andrea
Tramontana, Marta
Hansel, Katharina
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E384 - E388
[5] Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China
Yang, Nali
Ye, Yahui
Shao, Junyi
Wu, Hanwen
Xu, Qiuyang
Zhu, Jilin
Liu, Jingjing
Li, Zhiming
DERMATITIS, 2024, 35 : S39 - S46
[6] Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
Rob, Filip
Pinkova, Blanka
Sokolova, Kristyna
Kopuleta, Jana
Jiraskova Zakostelska, Zuzana
Cadova, Jana
JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
[7] Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
Torres, T.
Paiva-Lopes, M. J.
Goncalo, M.
Claro, C.
Oliveira, M.
Gomes, J.
Vieira, A. P.
Amoedo, P.
Alpalhao, M.
Nogueira, M.
Santiago, F.
Henrique, M.
Amaro, C.
Esteves, T.
Alves, J.
Cerejeira, D.
Mendes-Bastos, P.
Pestana, M.
Ramos, L.
Rocha, J.
Carvalho, R.
Teixeira, L.
Selores, M.
Mota, A.
Filipe, P.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2554 - 2559
[8] Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study
Georgakopoulos, Jorge R.
Sheka, Dropen
Rankin, Brian
Maliyar, Khalad
Rimke, Alexander
Prajapati, Vimal H.
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1308 - 1311
[9] 52-week evaluation of the efficacy of dupilumab for moderate to severe atopic dermatitis in clinical practice: A Canadian multicenter retrospective study
Jo, Christine E.
Georgakopoulos, Jorge R.
Ladda, Matthew
Ighani, Arvin
Drucker, Aaron
Mufti, Asfandyar
Yeung, Jensen
Piguet, Vincent
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB35 - AB35
[10] Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective study
Pirov, Eitan
Molho-Pessach, Vered
Cohen-Barak, Eran
Levitt, Jen A. Barak
Barzilai, Aviv
Bar, Jonathan
Renert-Yuval, Yael
Bar-Ilan, Efrat
Friedland, Rivka
Greenberger, Shoshana
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,

← 1 2 3 4 5 →